Find below videos and webinars on access and policy developed mainly for patient organisations and advocates. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation
Recording of the webinar held on 26 June 2024 on patient and clinician involvement in the EU HTA regulation. The webinar was organised by Myeloma Patients Europe (MPE) and Acute ...Leukemia Advocates Network (ALAN) and counted with the participation of the following speakers:
• Anke-Peggy Holtorf, moderator, Steering Committee member and project coordinator for the Patient and Citizen Involvement in HTA Interest Group, Health Technology Assessment international (HTAi)
• François Houÿez, Treatment Information and Access Director / Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS)
• Mihai Rotaru, Director Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Mirjana Huic, HTA independent specialist in HTA/EBM Centre, Croatia
• Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)[+] Show More
• Anke-Peggy Holtorf, moderator, Steering Committee member and project coordinator for the Patient and Citizen Involvement in HTA Interest Group, Health Technology Assessment international (HTAi)
• François Houÿez, Treatment Information and Access Director / Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS)
• Mihai Rotaru, Director Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Mirjana Huic, HTA independent specialist in HTA/EBM Centre, Croatia
• Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)[+] Show More
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation
Recording of the webinar held on 26 June 2024 on patient and clinician ...
EHA 2024 | Whose needs exactly? Unmet medical need in the EU pharmaceutical legislation
Maria Cavaller Bellaubi, Patient Engagement and Development Director, ...
EHA 2024 | Fair pricing: Does the value of new medicines in hematology justify the high prices?
Professor Doctor Uyl-de Groot explains fair pricing in haematology ...
MPE/ALAN Webinar | EU HTA
Recording of the webinar held by Myeloma Patients Europe (MPE) and ...
Masterclass 2024 | EU Health Technology Assessment Regulation
Interview filmed with Valentina Strammiello, Director of Programmes, ...
MPE Masterclass 2024 | Cross border medicine and trials access
Claudia Louati, Head of Policy at European Patients' Forum (EPF) ...
Webinar | Basics of medicines pricing in Europe
Recoding of the webinar "Basics of medicines pricing in Europe" held ...
ESMO 2023 | Access inequalities to modern treatments
MPE´s Co-Chief Executive Officer, Kate Morgan, explains the access ...
ESMO 2023 | Patient engagement and collaboration with national regulatory agencies
MPE Board President Lise-Lott Eriksson explains patient engagement and ...
Masterclass 2023 | Improving access to clinical trials in Central Eastern European (CEE) countries
Prof. Dr. Roman Hajek, Department of Hematooncology, University ...
Masterclass 2023 | Panel discussion on sequencing: Optimising the myeloma Pathway
Eric Low, Eric Low Consulting, explains what was discussed during the ...
Masterclass 2023 | Health Technology Assessment (HTA)
Neil Bertelsen, Steering Committee Member and past Chair of HTAi PCIG, ...
MPE Webinar: Access Barriers to Clinical Trials in CEE Countries
This is a recording of Prof. Dr. Karanfilski giving a summary of the ...
MPE Masterclass 2022 | Patient group involvement in HTA
Neil Bertelsen, Steering Committee Member/Past Chair HTAi Patient and ...
MPE Masterclass 2021 | Access to new treatments in CEE countries
Recording of the session "Access to new treatments. A clinical ...
1
of 2